Connection | Profiles RNS

Search Result Details

Back to Search Results

This page shows the details of why an item matched the keywords from your search.

Search Results

Foster, David A.

One or more keywords matched the following items that are connected to Foster, David A.

Item Type	Name
Academic Article	Suppression of hypoxia-inducible factor 2alpha restores p53 activity via Hdm2 and reverses chemoresistance of renal carcinoma cells.
Academic Article	Phospholipase D stabilizes HDM2 through an mTORC2/SGK1 pathway.
Academic Article	Suppression of AKT phosphorylation restores rapamycin-based synthetic lethality in SMAD4-defective pancreatic cancer cells.
Academic Article	High-dose rapamycin induces apoptosis in human cancer cells by dissociating mTOR complex 1 and suppressing phosphorylation of 4E-BP1.
Academic Article	Inhibition of fatty acid synthase induces pro-survival Akt and ERK signaling in K-Ras-driven cancer cells.
Academic Article	Apoptotic effects of high-dose rapamycin occur in S-phase of the cell cycle.
Academic Article	Aspartate Rescues S-phase Arrest Caused by Suppression of Glutamine Utilization in KRas-driven Cancer Cells.
Academic Article	Lipid sensing by mTOR complexes via de novo synthesis of phosphatidic acid.
Academic Article	Glutamine as an Essential Amino Acid for KRas-Driven Cancer Cells.
Academic Article	Phospholipase D overcomes cell cycle arrest induced by high-intensity Raf signaling.
Academic Article	Phospholipase D elevates the level of MDM2 and suppresses DNA damage-induced increases in p53.
Academic Article	Survival signals generated by estrogen and phospholipase D in MCF-7 breast cancer cells are dependent on Myc.
Academic Article	Myc stabilization in response to estrogen and phospholipase D in MCF-7 breast cancer cells.
Academic Article	Differential dependence of hypoxia-inducible factors 1 alpha and 2 alpha on mTORC1 and mTORC2.
Academic Article	Regulation of mTORC1 and mTORC2 complex assembly by phosphatidic acid: competition with rapamycin.
Concept	Proto-Oncogene Proteins
Concept	Proto-Oncogene Proteins c-myc
Concept	Proto-Oncogene Proteins p21(ras)
Concept	Proto-Oncogene Proteins c-raf
Concept	Proto-Oncogene Proteins c-akt
Concept	Proto-Oncogene Proteins c-mdm2
Academic Article	Inhibiting glutamine utilization creates a synthetic lethality for suppression of ATP citrate lyase in KRas-driven cancer cells.

Search Criteria

Proto Oncogenes

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support